Skip to main content
. 2022 Feb 7;75(1):e623–e629. doi: 10.1093/cid/ciac106

Figure 2.

Figure 2.

Protection against SARS-CoV-2 infection and COVID-19 hospitalization for each vaccine product during the pre- and post-Delta variant periods adjusted by Cox regression for age, immunosuppression, gender, race, number of visits, and Charlson comorbidity index. Abbreviations: CI, confidence interval; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.